TNXP
#3516
Tonix Pharmaceuticals Holding Corp. - Common Stock
13.5 8 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.15%
Changement Mensuel
+35.80%
Evolution sur 6 mois
+1.80%
Changement Annuel
-9.53%
Clôture Précédente
13.5 6
Open
13.3 4
Low
13.3 1
High
13.7 0
Volume
356
Financials
- Market Capitalization 232.91 M
- Employee 142
- Founded 2007
- CEO Seth Lederman
- Website www.tonixpharma.com
- Headquarter Nevada, United States
- FIGI BBG000LG8XM5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.07
ratio cours/chiffre d'affaires
10.14
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3504 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 15.70 USD | -16.18% | -5.82% | +15.53% | +35.81% | 230.45 M USD | ||
| 3509 |  NERV Minerva Neurosciences, Inc - Common Stock | 4.82 USD | -6.04% | -0.41% | +12.62% | +99.17% | 230.14 M USD | ||
| 3524 |  RNA Atrium Therapeutics, Inc. - Common Stock | 13.63 USD | -2.50% | +3.26% | +19.46% | -80.62% | 233.15 M USD | ||
| 3544 |  TARA Protara Therapeutics, Inc. - Common Stock | 3.82 USD | -4.26% | -0.78% | -2.05% | +20.89% | 225.74 M USD |